Polydex Pharmaceuticals Ltd (POLXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in U.S. thousands)
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Sales | 1,495 | 1,299 | 858 | 1,092 | 1,156 |
| Cost of Goods | 1,438 | 969 | 999 | 1,194 | 1,031 |
| Gross Profit | 57 | 329 | -141 | -102 | 125 |
| Operating Expenses | 648 | 1,295 | 1,240 | 401 | 233 |
| Operating Income | -153 | 4 | -382 | -309 | -77 |
| Interest Expense | 6 | 8 | 8 | 9 | 8 |
| Other Income | 6 | 8 | 8 | 9 | 8 |
| Pre-tax Income | -153 | 4 | -382 | -309 | -77 |
| Income Tax | N/A | 1 | 1 | 1 | N/A |
| Net Income Continuous | -153 | 3 | -383 | -310 | -77 |
| Net Income | $-153 | $3 | $-383 | $-310 | $-77 |
| EPS Basic Total Ops | -0.04 | 0.00 | -0.11 | -0.09 | -0.02 |
| EPS Basic Continuous Ops | -0.04 | 0.00 | -0.11 | -0.09 | -0.02 |
| EPS Diluted Total Ops | -0.04 | 0.00 | -0.11 | -0.09 | -0.02 |
| EPS Diluted Continuous Ops | -0.04 | 0.00 | -0.11 | -0.09 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.04 | 0.00 | -0.11 | -0.09 | -0.02 |
| EBITDA(a) | $-44 | $91 | $-294 | $-216 | $16 |